Clear Street Group Inc. Buys 5,722 Shares of Axon Enterprise, Inc $AXON

Clear Street Group Inc. lifted its stake in Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 235.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,150 shares of the biotechnology company’s stock after purchasing an additional 5,722 shares during the period. Clear Street Group Inc.’s holdings in Axon Enterprise were worth $4,629,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. New Millennium Group LLC bought a new position in Axon Enterprise during the third quarter worth about $29,000. Darwin Wealth Management LLC bought a new position in Axon Enterprise during the second quarter worth about $37,000. Creative Financial Designs Inc. ADV bought a new position in Axon Enterprise during the fourth quarter worth about $28,000. Sound Income Strategies LLC lifted its holdings in Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after acquiring an additional 44 shares in the last quarter. Finally, Camelot Portfolios LLC bought a new position in Axon Enterprise during the fourth quarter worth about $30,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

AXON opened at $441.73 on Friday. The business’s 50-day moving average price is $410.34 and its two-hundred day moving average price is $489.19. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91. The company has a market capitalization of $35.60 billion, a price-to-earnings ratio of 177.40, a P/E/G ratio of 8.03 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.91 million. During the same quarter last year, the business posted $1.47 EPS. The company’s revenue for the quarter was up 33.7% on a year-over-year basis. Equities analysts expect that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Analysts Set New Price Targets

AXON has been the topic of several recent analyst reports. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a report on Thursday, May 7th. Robert W. Baird set a $800.00 target price on Axon Enterprise in a report on Wednesday, February 25th. Morgan Stanley set a $600.00 target price on Axon Enterprise in a report on Thursday, May 7th. TD Cowen reduced their target price on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Finally, Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Read Our Latest Research Report on AXON

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This trade represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of Axon Enterprise stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the sale, the president directly owned 169,125 shares in the company, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 39,344 shares of company stock worth $19,267,315. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.